Critical Care

official impact factor 4.60

Open Access Highly Access

The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes

Greg Martin, Frank M Brunkhorst, Jonathan M Janes, Konrad Reinhart, David P Sundin, Kassandra Garnett and Richard Beale*

Critical Care 2009, 13:R103 doi:10.1186/cc7936

Accesses  

  • Last 30 days: 56 accesses
  • Last 365 days: 717 accesses
  • All time: 3975 accesses

Cited by

BioMed Central: 2 citations

Commentary   Subscription Highly Accessed

Drotrecogin alfa (activated) ... a sad final fizzle to a roller-coaster party

Derek C Angus Critical Care 2012, 16:107 (6 February 2012)

Research   Open Access Highly Accessed

Is Drotrecogin alfa (activated) for adults with severe sepsis, cost-effective in routine clinical practice?

M Zia Sadique, Richard Grieve, David A Harrison, Brian H Cuthbertson, Kathryn M Rowan Critical Care 2011, 15:R228 (26 September 2011)